is wegovy a glp 1 Novo Nordisk launches weight-loss pill in US, triggering price war | Pharmaceuticals industry Arrival of GLP-1 weight-loss pill
Description
This matters because injections are a barrier for some patients
Based on VigiBase, the World Health Organizations (WHO) adverse drug reaction database, intestinal obstructions are reported over 4.5 times more frequently with incretin-based drugs than with other diabetes medications [10]
Lu, S., Yin, H., Yu, O
These insights led to studies of the drug at a higher dose (3 mg) in obese patients who haven't yet got diabetes, but who are, nevertheless, at high risk
Absolutely quality glp1 alternative
Am J Physiol Endocrinol Metab 2010;298:E751-E760
